Zuo Wen-Jia,Jiang Yi-Zhou,Yu Ke-Da, et al. Activating HER2 mutations promote oncogenesis and resistance to HER2-targeted therapies in breast cancer [J].CANCER RESEARCH,2015,75.
APA:
Zuo Wen-Jia,Jiang Yi-Zhou,Yu Ke-Da,Shao Zhi-Ming.(2015).Activating HER2 mutations promote oncogenesis and resistance to HER2-targeted therapies in breast cancer .CANCER RESEARCH,75.
MLA:
Zuo Wen-Jia, et al. "Activating HER2 mutations promote oncogenesis and resistance to HER2-targeted therapies in breast cancer" .CANCER RESEARCH 75(2015).